234 related articles for article (PubMed ID: 20937296)
41. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
42. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
[TBL] [Abstract][Full Text] [Related]
43. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
Kyosseva SV; Chen L; Seal S; McGinnis JF
Exp Eye Res; 2013 Nov; 116():63-74. PubMed ID: 23978600
[TBL] [Abstract][Full Text] [Related]
44. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of pathological retinal neovascularization by semaphorin 3A.
Yu W; Bai Y; Han N; Wang F; Zhao M; Huang L; Li X
Mol Vis; 2013; 19():1397-405. PubMed ID: 23825919
[TBL] [Abstract][Full Text] [Related]
46. Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells.
Kim CS; Son SJ; Kim EK; Kim SN; Yoo DG; Kim HS; Ryoo SW; Lee SD; Irani K; Jeon BH
Cardiovasc Res; 2006 Feb; 69(2):520-6. PubMed ID: 16325162
[TBL] [Abstract][Full Text] [Related]
47. The APE1 redox inhibitor E3330 reduces collective cell migration of human breast cancer cells and decreases chemoinvasion and colony formation when combined with docetaxel.
Guerreiro PS; Corvacho E; Costa JG; Saraiva N; Fernandes AS; Castro M; Miranda JP; Oliveira NG
Chem Biol Drug Des; 2017 Oct; 90(4):561-571. PubMed ID: 28303665
[TBL] [Abstract][Full Text] [Related]
48. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
49. Cytoplasmic localization and redox cysteine residue of APE1/Ref-1 are associated with its anti-inflammatory activity in cultured endothelial cells.
Park MS; Kim CS; Joo HK; Lee YR; Kang G; Kim SJ; Choi S; Lee SD; Park JB; Jeon BH
Mol Cells; 2013 Nov; 36(5):439-45. PubMed ID: 24213673
[TBL] [Abstract][Full Text] [Related]
50. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
51. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
52. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
53. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
54. Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT.
Li Q; Zhou ZW; Duan W; Qian CY; Wang SN; Deng MS; Zi D; Wang JM; Mao CY; Song G; Wang D; Westover KD; Xu CX
J Exp Clin Cancer Res; 2021 Jul; 40(1):220. PubMed ID: 34210327
[TBL] [Abstract][Full Text] [Related]
55. The redox function of apurinic/apyrimidinic endonuclease 1 as key modulator in photodynamic therapy.
Franchi LP; de Freitas Lima JEB; Piva HL; Tedesco AC
J Photochem Photobiol B; 2020 Oct; 211():111992. PubMed ID: 32805556
[TBL] [Abstract][Full Text] [Related]
56. Dual Function of Secreted APE1/Ref-1 in TNBC Tumorigenesis: An Apoptotic Initiator and a Regulator of Chronic Inflammatory Signaling.
Choi S; Lee YR; Kim KM; Choi E; Jeon BH
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012284
[TBL] [Abstract][Full Text] [Related]
57. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract][Full Text] [Related]
58. Interactions of apurinic/apyrimidinic endonuclease with a redox inhibitor: evidence for an alternate conformation of the enzyme.
Su D; Delaplane S; Luo M; Rempel DL; Vu B; Kelley MR; Gross ML; Georgiadis MM
Biochemistry; 2011 Jan; 50(1):82-92. PubMed ID: 21117647
[TBL] [Abstract][Full Text] [Related]
59. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
[TBL] [Abstract][Full Text] [Related]
60. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.
Song YJ; Lee JY; Joo HK; Kim HS; Lee SK; Lee KH; Cho CH; Park JB; Jeon BH
Biochem Biophys Res Commun; 2008 Mar; 368(1):68-73. PubMed ID: 18206643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
